Lawrence Rosen & Aldeyra Therapeutics

Lawrence Rosen: Lawrence Rosen, a founding partner of Rosen Law Firm, is mentioned as a key figure in the firm's success in securities class actions, which is handling the lawsuit against Aldeyra Therapeutics.

Aldeyra Therapeutics: Aldeyra Therapeutics is the primary defendant in multiple class action lawsuits filed by various law firms, alleging that the company made false and misleading statements regarding the clinical trials of its drug candidate, reproxalap. The company's stock price fell significantly after the United States — Food and Drug Administration issued a Complete Response Letter for reproxalap.